Second malignant neoplasms following hematopoietic stem cell transplantation.

Friedman DL, Leisenring W, Schwartz JL, Deeg HJ
Int J Hematol. 2004 79 (3): 229-34

PMID: 15168589 · DOI:10.1532/ijh97.03178

Hematopoietic stem cell transplantation is being successfully used to treat a variety of malignant and nonmalignant disorders. This therapy has resulted in an increasing number of survivors who are at risk for adverse long-term outcomes, including the development of second and subsequent malignant neoplasms. We review the incidence and spectrum of posttransplantation malignancies and discuss risk factors and future directions for research.

MeSH Terms (6)

Hematopoietic Stem Cell Transplantation Humans Incidence Neoplasms, Second Primary Risk Factors Survivors

Connections (1)

This publication is referenced by other Labnodes entities: